Logo Logo

Yearly Archives: "2021"

  1. Home
  2. 2021
  3. Page 2
Jun 10, 2021
Congratulations to Dr. Robert Lisak: recipient of ANA’s Distinguished Neurology Teacher Award
MS Community, Partners
The CMSC Board, staff, and members would like to congratulate Dr. Robert Lisak for his selection as a recipient of the 2021 Distinguished [...]
Elizabeth Porco
Read More
...30
0
May 07, 2021
Study on cognitive processing speed changes in RMS subjects treated with Ozanimod
INforMS, Partners
Bristol Myers Squibb is conducting a Phase 3b Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing [...]
Elizabeth Porco
Read More
...31
0
Apr 28, 2021
#MSVisibility virtual concert: recording now available
INforMS, MS Community
#MSVisibility Virtual Concert Thank you for your interest in the first-ever #MSVisibility Virtual Concert, a free event to celebrate and [...]
Elizabeth Porco
Read More
...33
0
Apr 28, 2021
Phase 1/2 study to evaluate the safety and efficacy of ATA188 in progressive multiple sclerosis
INforMS
The purpose of this study is to evaluate the safety and tolerability of ATA188 as a monotherapy in Parts 1 and 2, to determine the [...]
Elizabeth Porco
Read More
...30
0
Apr 16, 2021
New data for Ocrevus disease progression (ocrelizumab) reinforce significant slowing
INforMS, Partners
– 85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity [...]
Elizabeth Porco
Read More
...28
0
Apr 07, 2021
New Genentech data at 2021 AAN highlight impact & breadth of neuroscience portfolio
INforMS, Partners
Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy [...]
Elizabeth Porco
Read More
...31
0
Mar 22, 2021
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry
Basic Science, COVID-19, Resources
Key Points Question How do patients with multiple sclerosis (MS) who have COVID-19 fare and are there patient and disease [...]
Jennifer Pichardo
Read More
...33
0
Mar 19, 2021
Janssen announces U.S. FDA approval of PONVORY™ (ponesimod)
INforMS, Partners
Head-to-head pivotal clinical trial results showed PONVORY™ treatment led to nearly a third fewer annual relapses than [...]
Elizabeth Porco
Read More
...31
0
Mar 08, 2021
NeurologyLive® & the CMSC launches MS Cure Connections® Video Series
CMSC PR, Partners
A diverse panel including an expert neurologist, a psychologist, a patient, and a care partner discuss the patient's journey with [...]
Elizabeth Porco
Read More
...33
0
Mar 07, 2021
CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis
CMSC Consensus Statements, Disease Modifying Therapies
This consensus document was developed by an international panel of experts on neurofilament biomarker research and clinical applications in [...]
admin
Read More
...50
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM